Vera Therapeutics VERA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's total equity?
- Vera Therapeutics (VERA) reported total equity of $499.7M in Q1 2026.
- How has Vera Therapeutics's total equity changed year-over-year?
- Vera Therapeutics's total equity decreased by 6.6% year-over-year, from $535M to $499.7M.
- What is the long-term trend for Vera Therapeutics's total equity?
- Over 5 years (2020 to 2025), Vera Therapeutics's total equity has grown at a 46.6% compound annual growth rate (CAGR), from -$89.35M to $604.52M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.